EUVIMEDEUVIMED entdecken
Crossref

Diagnostic utility of p53 immunohistochemistry in Barrett’s neoplasia: practice patterns and diagnostic challenges in a referral laboratory

Preithy Uthamalingam iD, Thomas Meares, Sheldon Russell, Jacqueline Bentel, M Priyanthi Kumarasinghe

Virchows Archiv · 14.11.2026

DOI: 10.1007/s00428-026-04784-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 14.11.2026. Verfasst von Preithy Uthamalingam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Dr, Murdoch, WA, 6150, Australia. preith…. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Our study explored the practical application of p53-IHC in Barrett’s dysplasia, its diagnostic impact and interpretative challenges within a referral pathology service using a validated assay.

Methods

A retrospective observational audit was performed of 468 patients with biopsy-confirmed Barrett’s oesophagus identified during a 12-month period, with longitudinal review of 1,657 procedural sets(cases) over a 30-year interval. Cases demonstrating discordance between morphology and p53-IHC, or cases with indeterminate staining patterns, underwent blinded consensus review integrating morphology and p53-IHC findings. Results p53-IHC was performed in 408/1657 (24.6%) cases. Among 234 cases with reported results, 95.3% of staining patterns were classified as either wild-type or mutant. Overall, a mutant pattern of p53 immunostaining was strongly associated with a diagnosis of definite dysplasia in routine reports ( p < 0.00001), noting that p53-IHC contributed to some of these diagnoses. Mutant patterns were more frequent in high grade dysplasia (HGD) than in low grade dysplasia, but p53-IHC did not reliably distinguish between grades of dysplasia. Review of discrepant cases resulted in reclassification of p53-IHC interpretation in 14/27 (51.9%) cases and upgrade of 5 cases (50%) with diagnosis of indefinite for dysplasia (IND) to definite dysplasia.

Conclusion

Our study provides a pragmatic approach for selective use of p53-IHC in Barrett’s dysplasia, particularly for reclassifying morphological IND and for confirming HGD, especially when the abnormality represented is low volume. A practical threshold for recognising mutant p53-IHC staining patterns and integration of p53-IHC with morphological assessment may improve diagnostic consistency, reduce the IND category and strengthen interpretative expertise.

Schlagwörter

Stichwörter der Autor:innen

Barrett’s dysplasiaIndefinite for dysplasiaIndeterminate patternsP53 immunohistochemistryTissue diagnosis

Autor:innen und Institutionen

  • Department of Anatomical Pathology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Dr, Murdoch, WA, 6150, Australia. preithyu@gmail.com.
  • Department of Anatomical Pathology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, 11 Robin Warren Dr, Murdoch, WA, 6150, Australia.
  • School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Curtin University Medical School, Perth, Western Australia, Australia.

ORCID-Profile: Preithy Uthamalingam

Zitieren

APA

Uthamalingam, P., Meares, T., Russell, S., Bentel, J., & Kumarasinghe, M. P. (2026). Diagnostic utility of p53 immunohistochemistry in Barrett’s neoplasia: practice patterns and diagnostic challenges in a referral laboratory. Virchows Archiv. https://doi.org/10.1007/s00428-026-04784-9

Vancouver

Uthamalingam P, Meares T, Russell S, Bentel J, Kumarasinghe MP. Diagnostic utility of p53 immunohistochemistry in Barrett’s neoplasia: practice patterns and diagnostic challenges in a referral laboratory. Virchows Archiv. 2026. doi:10.1007/s00428-026-04784-9

BibTeX
@article{Uthamalingam2026,
  author = {Uthamalingam, Preithy and Meares, Thomas and Russell, Sheldon and Bentel, Jacqueline and Kumarasinghe, M Priyanthi},
  title = {Diagnostic utility of p53 immunohistochemistry in Barrett’s neoplasia: practice patterns and diagnostic challenges in a referral laboratory},
  journal = {Virchows Archiv},
  year = {2026},
  doi = {10.1007/s00428-026-04784-9}
}
Kostenlos starten →